TONI GARNER: Open Payments
NPI 1598013815 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,674 in 162 payments from 15 companies in 2025. Trend: 2023 $1,597 · 2024 $1,626 · 2025 $2,674
Food & beverage: $2,674
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $636 |
| ABBVIE INC. | 35 | $560 |
| Otsuka America Pharmaceutical, Inc. | 24 | $282 |
| PFIZER INC. | 20 | $218 |
| Lundbeck LLC | 12 | $209 |
| GlaxoSmithKline, LLC. | 16 | $206 |
| HEARTFLOW, INC. | 1 | $147 |
| Amgen Inc. | 11 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
Products named: REXULTI, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, UBRELVY, VRAYLAR, NURTEC ODT, FFRct.
Industry payments across AR — which companies pay providers there.
